Arcus Biosciences, Inc.
NYSE:RCUS
9.6 (USD) • At close June 4, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 28 | 26 | 48 | 39 | 145 | 31 | 32 | 29 | 25 | 0.345 | 33.581 | 26.759 | 18.005 | 354.499 | 9.461 | 9.461 | 9.461 | 9.487 | 64.53 | 1.75 | 1.75 | 9.75 | 1.75 | 1.75 | 1.75 | 1.562 | 4.291 | 1.25 | 1.25 | 1.25 | 0.163 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 2 | 3 | 5 | 3 | 4 | 4 | 3.429 | 3.609 | 3.529 | 3.433 | 2.473 | 71.254 | 68.771 | 66.387 | 48.712 | 51.801 | 35.693 | 23.142 | 20.686 | 17.241 | 24.999 | 15.554 | 11.436 | 12.859 | 13.699 | 11.652 | 12.146 | 21.435 | 7.834 | 5.804 |
| Brutowinst
| 28 | 23 | 48 | 37 | 142 | 26 | 29 | 25 | 21 | -3.084 | 29.972 | 23.23 | 14.572 | 352.026 | -61.793 | -59.31 | -56.926 | -39.225 | 12.729 | -33.943 | -21.392 | -10.936 | -15.491 | -23.249 | -13.804 | -9.874 | -8.568 | -12.449 | -10.402 | -10.896 | -21.272 | -7.834 | -5.804 |
| Brutowinstmarge
| 1 | 0.885 | 1 | 0.949 | 0.979 | 0.839 | 0.906 | 0.862 | 0.84 | -8.939 | 0.893 | 0.868 | 0.809 | 0.993 | -6.531 | -6.269 | -6.017 | -4.135 | 0.197 | -19.396 | -12.224 | -1.122 | -8.852 | -13.285 | -7.888 | -6.321 | -1.997 | -9.959 | -8.322 | -8.717 | -130.503 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 122 | 101 | 123 | 115 | 109 | 93 | 82 | 84 | 81 | 80 | 76.684 | 69.905 | 61.211 | 49.936 | 71.254 | 68.771 | 66.387 | 48.712 | 51.801 | 35.693 | 23.142 | 20.686 | 17.241 | 24.999 | 15.554 | 11.436 | 12.859 | 13.699 | 11.652 | 12.146 | 21.435 | 7.834 | 5.804 |
| Algemene en administratieve kosten
| 28 | 28 | 30 | 30 | 32 | 29 | 30 | 28 | 30 | 28 | 26.294 | 25.836 | 23.974 | 23.296 | 16.343 | 16.826 | 15.821 | 12.787 | 11.177 | 11.432 | 7.008 | 6.591 | 7.758 | 5.911 | 4.969 | 3.61 | 3.577 | 3.45 | 2.929 | 2.448 | 1.862 | 1.83 | 1.496 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 28 | 28 | 30 | 28 | 32 | 29 | 30 | 28 | 30 | 28 | 26.294 | 25.836 | 23.974 | 23.296 | 16.343 | 16.826 | 15.821 | 12.787 | 11.177 | 11.432 | 7.008 | 6.591 | 7.758 | 5.911 | 4.969 | 3.61 | 3.577 | 3.45 | 2.929 | 2.448 | 1.862 | 1.83 | 1.496 |
| Overige kosten
| 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 150 | 129 | 153 | 143 | 141 | 122 | 112 | 112 | 111 | 108 | 102.978 | 95.741 | 85.185 | 73.232 | 87.597 | 85.597 | 82.208 | 61.499 | 62.978 | 47.125 | 30.15 | 27.277 | 24.999 | 30.91 | 20.523 | 15.046 | 16.436 | 17.149 | 14.581 | 14.594 | 23.297 | 9.664 | 7.3 |
| Bedrijfsresultaat
| -122 | -103 | -105 | -106 | -16 | -91 | -80 | -83 | -86 | -74 | -69.397 | -68.982 | -67.18 | 281.267 | -78.136 | -76.136 | -72.747 | -52.012 | 1.552 | -45.375 | -28.4 | -17.527 | -23.249 | -29.16 | -18.773 | -13.484 | -12.145 | -15.899 | -13.331 | -13.344 | -23.134 | -9.664 | -7.3 |
| Bedrijfsresultaat ratio
| -4.357 | -3.962 | -2.188 | -2.718 | -0.11 | -2.935 | -2.5 | -2.862 | -3.44 | -214.493 | -2.067 | -2.578 | -3.731 | 0.793 | -8.259 | -8.047 | -7.689 | -5.482 | 0.024 | -25.929 | -16.229 | -1.798 | -13.285 | -16.663 | -10.727 | -8.633 | -2.83 | -12.719 | -10.665 | -10.675 | -141.926 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 10 | 9 | 13 | 13 | -8 | 11 | 11 | 9 | 8 | 6.981 | 4.478 | 2.35 | 0.191 | -0.084 | 0.161 | 0.166 | 0.154 | 0.159 | 0.27 | 0.301 | 0.647 | 0.929 | 0.897 | 1.07 | 1.103 | 1.189 | 1.333 | 2.366 | 0.377 | 0.134 | 0.012 | 0.114 | 0.1 |
| Inkomen voor belasting
| -112 | -94 | -92 | -93 | -4 | -80 | -69 | -74 | -78 | -67 | -64.919 | -66.632 | -66.989 | 281.183 | -77.975 | -75.97 | -72.593 | -51.853 | 1.822 | -45.074 | -27.753 | -16.598 | -22.352 | -28.09 | -17.67 | -12.295 | -10.812 | -13.533 | -12.954 | -13.21 | -23.122 | -9.55 | -7.2 |
| Inkomen voor belasting ratio
| -4 | -3.615 | -1.917 | -2.385 | -0.028 | -2.581 | -2.156 | -2.552 | -3.12 | -194.203 | -1.933 | -2.49 | -3.721 | 0.793 | -8.242 | -8.03 | -7.673 | -5.466 | 0.028 | -25.757 | -15.859 | -1.702 | -12.773 | -16.051 | -10.097 | -7.871 | -2.52 | -10.826 | -10.363 | -10.568 | -141.853 | 0 | 0 |
| Belastingkosten
| 0 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | -0.004 | -4.478 | -2.35 | 1.004 | 1.815 | -0.1 | -0.1 | 0.438 | -1.82 | -0.258 | -0.131 | -0.482 | -0.856 | -1.254 | -1.482 | -1.534 | -2.459 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nettowinst
| -112 | -94 | -92 | -93 | -4 | -81 | -71 | -75 | -80 | -66.996 | -60.441 | -64.282 | -67.993 | 279.368 | -77.975 | -75.97 | -72.593 | -51.853 | 1.822 | -45.074 | -27.753 | -16.598 | -22.352 | -28.09 | -17.67 | -12.295 | -10.812 | -13.533 | -12.954 | -13.21 | -23.122 | -9.55 | -7.2 |
| Nettowinstmarge
| -4 | -3.615 | -1.917 | -2.385 | -0.028 | -2.613 | -2.219 | -2.586 | -3.2 | -194.191 | -1.8 | -2.402 | -3.776 | 0.788 | -8.242 | -8.03 | -7.673 | -5.466 | 0.028 | -25.757 | -15.859 | -1.702 | -12.773 | -16.051 | -10.097 | -7.871 | -2.52 | -10.826 | -10.363 | -10.568 | -141.853 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -1.14 | -1.03 | -1.01 | -1.02 | -0.046 | -1.08 | -0.95 | -1.02 | -1.1 | -0.92 | -0.84 | -0.9 | -0.96 | 3.97 | -1.11 | -1.09 | -1.08 | -0.82 | 0.03 | -0.93 | -0.63 | -0.38 | -0.51 | -0.64 | -0.41 | -0.28 | -0.25 | -0.32 | -1.37 | -0.54 | -0.94 | -0.39 | -0.29 |
| Verwaterde WPA
| -1.14 | -1.03 | -1.01 | -1.02 | -0.046 | -1.08 | -0.95 | -1.02 | -1.1 | -0.92 | -0.84 | -0.9 | -0.96 | 3.71 | -1.11 | -1.09 | -1.08 | -0.82 | 0.03 | -0.93 | -0.63 | -0.38 | -0.51 | -0.64 | -0.41 | -0.28 | -0.25 | -0.32 | -1.37 | -0.54 | -0.94 | -0.39 | -0.29 |
| EBITDA
| -122 | -88 | -89 | -91 | 0 | -75 | -65 | -70 | -73 | -63.468 | -60.775 | -62.592 | -65.141 | 283.916 | -77.012 | -75.15 | -71.693 | -52.012 | 1.552 | -44.719 | -27.414 | -16.671 | -22.363 | -28.277 | -17.82 | -12.537 | -11.171 | -14.984 | -12.503 | -12.578 | -22.402 | -9.036 | -6.814 |
| EBITDA ratio
| -4.357 | -3.385 | -1.854 | -2.333 | 0 | -2.419 | -2.031 | -2.414 | -2.92 | -183.965 | -1.81 | -2.339 | -3.618 | 0.801 | -8.14 | -7.943 | -7.578 | -5.482 | 0.024 | -25.554 | -15.665 | -1.71 | -12.779 | -16.158 | -10.183 | -8.026 | -2.603 | -11.987 | -10.002 | -10.062 | -137.436 | 0 | 0 |